Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia
BackgroundThe incidence and nature of excessive weight gain associated with antiretroviral treatment using tenofovir, lamivudine, and dolutegravir based regimens among patients living with human immunodeficiency virus has not been properly examined in Ethiopia. Therefore, this study aimed to assess...
Saved in:
| Main Authors: | Gashaw Sisay Chanie, Wagaye Atalay, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Yonas Sisay Aragie, Gizachew Kassahun Bizuneh, Mihret Melese, Rahel Belete Abebe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1394458/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART
by: Jennifer K. van Heerden, et al.
Published: (2025-04-01) -
Nail the diagnosis: Lamivudine-induced periungual pyogenic granulomas in PLHIV
by: Karthick Kumar Vaitheeswaran, et al.
Published: (2025-01-01) -
Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study
by: Mohammed Jemal, et al.
Published: (2025-07-01) -
Gestational exposure to HIV drugs alters intestinal mucosa-associated microbial diversity in adult rat offspring
by: Yaswanthi Yanamadala, et al.
Published: (2025-08-01) -
Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study
by: Julien De Greef, et al.
Published: (2025-07-01)